Established in 1992, Sichuan Xieli Pharmaceutical manufactures and trades a broad range of active pharmaceutical ingredients and plant extracts, including oncology and specialty compounds (regorafenib, tofacitinib, gefitinib, SN-38, obeticholic acid), traditional Chinese medicine actives (baicalin, berberine hydrogen sulfate, rotundine, artificial bezoar), and botanical extracts such as Zizyphus spinosa extract. Holding international approvals and backed by an experienced R&D staff and established brand reputation, the company serves customers across North America, Europe, Asia, the Middle East, and Africa.
No comments available.
Leave your rating & comment